W

Waystar Holding Corp
NASDAQ:WAY

Watchlist Manager
Waystar Holding Corp
NASDAQ:WAY
Watchlist
Price: 24.61 USD 1.86% Market Closed
Market Cap: $4.7B

Waystar Holding Corp
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Waystar Holding Corp
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
W
Waystar Holding Corp
NASDAQ:WAY
Research & Development
-$54.6m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Research & Development
-$767.4m
CAGR 3-Years
-14%
CAGR 5-Years
-21%
CAGR 10-Years
-28%
Inspire Medical Systems Inc
NYSE:INSP
Research & Development
-$103.2m
CAGR 3-Years
-15%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Research & Development
-$93m
CAGR 3-Years
-14%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Research & Development
-$87.7m
CAGR 3-Years
5%
CAGR 5-Years
-6%
CAGR 10-Years
-10%
Certara Inc
NASDAQ:CERT
Research & Development
-$41m
CAGR 3-Years
-13%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
No Stocks Found

Waystar Holding Corp
Glance View

Market Cap
4.7B USD
Industry
Health Care

Waystar Holding Corp. sits at the intersection of healthcare and technology, quietly revolutionizing the financial infrastructure of the medical industry. Born from a merger of two industry stalwarts, Navicure and ZirMed, Waystar has gained a reputation for offering comprehensive revenue cycle management solutions. The company's primary mission is to simplify and streamline the healthcare reimbursement process, an area historically fraught with complexity and inefficiency. By leveraging advanced cloud-based technology and a suite of intelligent tools, Waystar enables healthcare providers to process claims, track payments, and manage denials with unprecedented efficiency, thus reducing administrative costs and improving financial outcomes. Financially, Waystar thrives by licensing its innovative platform to a broad range of healthcare providers, from sprawling hospital systems to smaller clinics and physician groups. These subscriptions are often based on the scale and complexity of the healthcare entities' needs, providing Waystar with a steady stream of predictable revenue. Additionally, the company capitalizes on transaction-based fees from clearinghouse operations, fiduciary in facilitating billions of dollars in healthcare transactions. By embedding itself as an essential cog in the healthcare revenue machinery, Waystar not only ensures its financial health but also sets the benchmark for technological advancement in an industry increasingly reliant on digital solutions.

WAY Intrinsic Value
29.83 USD
Undervaluation 18%
Intrinsic Value
Price
W

See Also

What is Waystar Holding Corp's Research & Development?
Research & Development
-54.6m USD

Based on the financial report for Dec 31, 2025, Waystar Holding Corp's Research & Development amounts to -54.6m USD.

What is Waystar Holding Corp's Research & Development growth rate?
Research & Development CAGR 3Y
-19%

Over the last year, the Research & Development growth was -12%. The average annual Research & Development growth rates for Waystar Holding Corp have been -19% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett